Shankar Balasubramanian

Sir
Shankar Balasubramanian
FRS FMedSci
Born (1966-09-30) 30 September 1966 (age 57)[2]
Madras, Madras State
(now Chennai, Tamil Nadu), India
NationalityBritish
Alma materUniversity of Cambridge
Known for
Awards
Scientific career
Institutions
ThesisStudies on the reaction mechanism of chorismate synthase (1992)
Doctoral advisorChris Abell
Doctoral studentsJulian Huppert[3][4]
Websitewww.ch.cam.ac.uk/group/shankar https://www.cruk.cam.ac.uk/research-groups/balasubramanian-group

Sir Shankar Balasubramanian (born 30 September 1966)[2] is an Indian-born British chemist[5][6] and Herchel Smith Professor[7] of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge,[8][9] Senior Group Leader at the Cancer Research UK Cambridge Institute[10] and Fellow of Trinity College, Cambridge.[11] He is recognised for his contributions in the field of nucleic acids.[12] He is scientific founder of Solexa[13][14] and biomodal (formally Cambridge Epigenetix).[15][16]

  1. ^ Cite error: The named reference embo was invoked but never defined (see the help page).
  2. ^ a b c Anon (2017). "Balasubramanian, Prof. Shankar". Who's Who (online Oxford University Press ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.256669. (Subscription or UK public library membership required.)
  3. ^ Huppert, J. L.; Balasubramanian, S. (2005). "Prevalence of quadruplexes in the human genome". Nucleic Acids Research. 33 (9): 2908–2916. doi:10.1093/nar/gki609. PMC 1140081. PMID 15914667.
  4. ^ Huppert, Julian Leon (2005). Studies on genomic G-quadruplexes. lib.cam.ac.uk (PhD thesis). University of Cambridge. OCLC 885437272. EThOS uk.bl.ethos.604822.
  5. ^ Balasubramanian, S (2007). "From DNA to mountain climbing. Shankar Balasubramanian talks to Alison Stoddart about his research and other interests". Molecular BioSystems. 3 (5): B37. PMID 17582897.
  6. ^ Balasubramanian, S (2013). "An interview with Shankar Balasubramanian". Trends in Biochemical Sciences. 38 (4): 170–1. doi:10.1016/j.tibs.2013.02.006. PMID 23522090.
  7. ^ "University of Cambridge, 2011. Herchel Smith Academics .". Archived from the original on 17 November 2012. [Accessed 8 April 2013].
  8. ^ "University of Cambridge, 2013. The Balasubramanian Group.". [Accessed 4 April 2013].
  9. ^ "Professor Sir Shankar Balasubramanian FMedSci FRS". Yusuf Hamied Department of Chemistry. Retrieved 13 December 2021.
  10. ^ Cite error: The named reference Cancer Research UK Cambridge Institute 2021 was invoked but never defined (see the help page).
  11. ^ "Master & Fellows". Trinity College Cambridge. 10 November 2021. Retrieved 13 December 2021.
  12. ^ Shankar Balasubramanian's publications indexed by the Scopus bibliographic database. (subscription required)
  13. ^ Illumina, 2013. SBS Technology.[online] Available at: <"History of Illumina Sequencing". Archived from the original on 9 October 2014. Retrieved 21 October 2014.> [Accessed 8 April 2013]
  14. ^ Bentley, D. R.; Balasubramanian, S.; Swerdlow, H. P.; Smith, G. P.; Milton, J.; Brown, C. G.; Hall, K. P.; Evers, D. J.; Barnes, C. L.; Bignell, H. R.; Boutell, J. M.; Bryant, J.; Carter, R. J.; Keira Cheetham, R.; Cox, A. J.; Ellis, D. J.; Flatbush, M. R.; Gormley, N. A.; Humphray, S. J.; Irving, L. J.; Karbelashvili, M. S.; Kirk, S. M.; Li, H.; Liu, X.; Maisinger, K. S.; Murray, L. J.; Obradovic, B.; Ost, T.; Parkinson, M. L.; et al. (2008). "Accurate whole human genome sequencing using reversible terminator chemistry". Nature. 456 (7218): 53–59. Bibcode:2008Natur.456...53B. doi:10.1038/nature07517. PMC 2581791. PMID 18987734.
  15. ^ "Shankar Balasubramanian". biomodal integrates multiple modes of biology from a single sample in a single experiment to provide transformative insights into health and disease. 19 January 2020. Retrieved 13 December 2021.
  16. ^ "Shankar BALASUBRAMANIAN". companieshouse.gov.uk. London: Companies House. Archived from the original on 6 July 2016.